Hunter Syndrome (MPSII) is a rare, progressive genetic disorder with approximately 2,000 boys afflicted in the world today. These boys are born lacking a critical enzyme that clears cellular waste from their bodies. Hunter Syndrome, in its severe form, causes progressive loss of physical and cognitive functions, slowly and painfully robbing children of their ability to walk, talk, eat, and recognize loved ones. In the severe form of Hunter Syndrome, most children die in their early teens. Currently, the only approved treatment is a weekly 4-hour infusion that can slow some of the physical symptoms, but it does not prevent the cognitive decline and more aggressive symptoms of this relentless disease. Nor is it a cure. The infusions cost $400,000 a year, per patient.